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Abstract
Inflammatory response is a kind of nonspecific immune response, with the central link of vascular response, which is mainly
manifested by changes in neutrophils and vascular endothelial cells. In recent years, the in vivo and in vitro role of
intravenous anesthetic propofol in inhibiting inflammatory response has been attracting more and more attention, but the
anti-inflammatory mechanisms of propofol for mononuclear cells still remain undefined. In this study, proteomics analysis
was applied to investigate protein expression profile changes in serum mononuclear cells following intervention of rats with
endotoxemia using propofol. After two-dimensional electrophoresis and mass spectrometric identification, it has been
found that the protein Annexin A1 was up-regulated in the propofol intervention group. Annexin A1 is a glucocorticoid-
dependent anti-inflammatory protein. After detection using ELISA and Western blot assays, it has also been found that
propofol can not only promote the expression of Annexin A1, but also inhibit the phosphorylation level of p38 and release
of inflammatory factors (IL-1b, IL-6 and TNF-a) in rats with endotoxemia. In order to further determine the role of up-
regulated expression of Annexin A1 in anti-inflammation of propofol, this gene was silenced in vitro in human THP-1 cells,
to detect the phosphorylation status of p38 and release of inflammatory factors. The results show that Annexin A1 can
negatively regulate phosphorylation of p38 and release of IL-1b, IL-6 and TNF-a in THP-1 cells following propofol
intervention and lipopolysaccharide (LPS) stimulation. Our results clearly indicate that propofol can up-regulate Annexin A1
to inhibit the phosphorylation level of p38 and release of IL-1b, IL-6 and TNF-a, so as to inhibit inflammatory response.
Therefore, it can be speculated that Annexin A1 might be the key signaling protein in the in vivo and in vitro anti-
inflammatory mechanisms of propofol.
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Introduction
Sepsis is a kind of systemic inflammatory response syndrome
caused by a variety of pathogenic microorganisms or their toxins
[1,2]. Severe sepsis can lead to multiple organ dysfunction
syndrome, which accounts for one of the major causes of high
mortality in ICU patients [3,4]. Endotoxin is one of the structural
constitutions of the outer membrane of the cell wall in Gram-
negative bacteria. Its chemical essence is LPS, which is the major
factor inducing sepsis [5]. LPS can extensively act on a variety of
tissues and organs in the body [5]. Mononuclear cells, neutrophils
and endothelial cells are the major effector cells [6,7]. Therefore,
studies on the molecular mechanisms of sepsis or endotoxemia
mainly concentrate on the three effector cells.
Propofol is an intravenous general anesthetic [8]. Due to its fast
onset of action, in addition to its characteristics of regaining full
consciousness rapidly without accumulation during continuous
infusion, it is widely used in anesthesia induction and maintenance,
as well as sedation for ICU patients [9]. In recent years, the anti-
inflammatory role of propofol has gradually attracted people’s
interest [10–14]. Many studies have shown that propofol can:
inhibit neutrophil adhesion to vascular endothelial cells [15];
scavenge oxygen free radicals and inhibit oxidative damage [16];
inhibit the release of inflammatory factors like TNF-a, IL-6 and IL-
b [16–18]. Though there has been a common understanding on the
role of propofol in inhibiting inflammatory response, the specific
mechanism still remains unclear and there have been no complete
theoretical basis to guide clinical practice, which greatly limits the
application of propofol in the anti-inflammatory domain.
In this study, the impact of propofol on microcirculation of the
model of LPS-stimulated inflammation was investigated using
proteomics analysis from effector cells-mononuclear cells of sepsis,
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e27890including the impact on the serum cytokine profile and the protein
expression profile in serum mononuclear cells, to explore the key
signaling molecules mediating the anti-inflammatory effect of
propofol and the signaling pathway. Mononuclear cells were
further verified for in-depth study of the anti-inflammatory
mechanism of propofol for mononuclear cells.
Results
Quantitative comparison and identification of protein
spots on 2D gels
To determine the change of monocyte proteins profile in
response to LPS and propofol, gel-based comparative proteomic
analysis was performed. As shown in Fig. 1, eighteen protein spots
were found to be significantly altered. Fifteen of these protein spots
were successfully identified by MALDI-TOF MSMS and by
subsequent comparative sequence search in the Mascot database
(Table 1). Among them, destrin and glutathione peroxidase 1 were
substantially up-regulated in the control, LPS and LPS+propofol
groups. UMP-CMP kinase and myosin-9 had the lowest
expression in control group; While cofilin-1, ATP synthase subunit
alpha, mitochondrial precursor and hemoglobin subunit alpha had
the lowest expression in LPS group. In addition, the expression of
protein S100-A8, L-lactate dehydrogenase A chain, peptidyl-prolyl
cis-trans isomerase B precursor, peptidyl-prolyl cis-trans isomer-
ase, mitochondrial precursor and Annexin A1 increased dramat-
ically only in LPS+propofol group. Incontrast, the expression of
ubiquitin reached to highest level just in control group, and S-
phage kinase-associated protein 1 emerged only in LPS group.
Verification of up-regulation of Annexin A1 in
LPS+propofol group by Western blot in endotoxaemic
rats
As gel-based proteomic analysis showed that the expression of
Annexin A1 increased dramatically in LPS+propofol group,
Annexin A1 was elected for further investigation. The corre-
sponding differential expression patterns identified by 2D
electrophoresis and the MALDI-TOF mass spectra are shown in
Fig. 2. Annexin A1 is a 37 000 molecular weight anti-
inflammatory protein induced by glucocorticoids and mediates
some of the beneficial actions of glucocorticoids, such as inhibition
of cellular proliferation [19], anti-inflammatory effects [20–22],
the regulation of cell differentiation [23] and membrane trafficking
[24,25]. To more rigorously study the effect of propofol on the
expression of Annexin A1 in monocytes, 36 animals were divided
into six groups control group, LPS group, propofol group,
LPS+propofol group, intralipid group and LPS+intralipid. An-
nexin A1 expression in monocytes of each group was determined
by Western blot. As shown in Fig. 3A, the amount of Annexin A1
in monocytes showed no statistical difference both in control,
intralipid, and LPS groups(P.0.05). However, in the monocytes of
propofol and LPS+propofol group, the expression of Annexin A1
increased dramatically in accordance with our 2D gels results.
These results indicated that propofol can promote the expression
of Annexin A1 in the monocytes of endotoxaemic rats. The total
b-actin loaded on SDS-PAGE was used as internal control
(Fig. 3B).
Propofol inhibits the activation of p38 and release of IL-
1b, IL-6, and TNF-a in endotoxaemic rats
As it has been reported that Annexin A1 is a negative regulator
of IL-1b, IL-6, and TNF-a and has inhibitory effects on the
activation of p38 MAPK signal transduction pathway(12). Our 2D
and Western Blot results showed that in endotoxaemic rats,
propofol promotes the expression of Annexin A1 of monocytes in
the blood. Therefore, we further studied the effect of propofol on
the activation of p38 and release of IL-1b, IL-6, and TNF-a in
endotoxaemic rats. Without the treatment of LPS, the phosphor-
ylation of p38 remains in a low basal levels both in intralipid and
propofol group. LPS dramatically increased the phosphorylation
level of p38 in the monocytes, and this effect could be partially
inhibited by propofol(Fig. 3C). The total p38 and b-actin loaded
on SDS-PAGE was used as internal control (Fig. 3B). Then the
sera amount of IL-1b, IL-6, and TNF-a were measured by ELISA
in all the four groups. As shown in Fig. 4, sera level of IL-1b, IL-6,
and TNF-a showed no difference between intralipid control and
propofol group. LPS could obviously increase the amount of IL-
1b, IL-6, and TNF-a in the serum. This effect of LPS could also be
partially inhibited by propofol.
The impact of propofol on Annexin A1 and
phosphorylation of p38 following LPS stimulation was
validated and the time effects
Human monocytic cell line-THP-1 was selected for in vitro
study of the anti-inflammatory mechanism of propofol. First, the
concentration impact(treated for 5, 10, 20, 30, 50 mg/ml) of
propofol on Annexin A1 was validated. Propofol treatment
increased the expression of Annexin A1 in a concentration-
dependent manner (Fig. 5A). Since we observed that propofol
(20 mg/ml) caused significant effect of Annexin A1 (P,0.01,
Fig. 5B), this treatment condition was used in the following
experiments. Then the impact of propofol on Annexin A1 and
phosphorylation of p38 following LPS stimulation was validated
and the time effects(treated for 0.5, 1, 2, 6 h) were analyzed. The
results showed that propofol can activate the expression of
Annexin A1 no matter there was LPS stimulation or not and the
effect was the most obvious at 6 h (Fig. 5C). Correspondingly,
propofol can inhibit LPS-induced increase in the phosphorylation
level of p38 and the inhibitory effect on phosphorylation of p38
was significant at 2 h and 6 h following propofol treatment
(Fig. 5E). The solvent of propofol is intralipid, which is reported to
have the anti-inflammatory effect in many literatures. Thus, after
comparison of intralipid and propofol in vitro study of this
experiment, it has been found that intralipid can not activate the
expression of Annexin A1, nor inhibit the phosphorylation of p38
at 6 h.(Fig. 5J, I)
The release of IL-1b, IL-6 and TNF-a in the supernatant of
LPS-stimulated THP-1 cells in vitro
The supernatant of LPS-stimulated THP-1 cells of IL-1b, IL-6,
and TNF-a were measured by ELISA in all the four groups. As
shown in Fig. 6, supernatant level of IL-1b, IL-6, and TNF-a
showed no difference between contrtol control and propofol group
(P.0.05). LPS could obviously increase the amount of IL-1b, IL-6,
and TNF-a in the supernatant (P,0.01). This effect of LPS could
also be partially inhibited by propofol (P,0.05).
After inhibition of Annexin A1 in THP-1, the expression of
phosphorylation of p38 and the release of IL-1b, IL-6 and
TNF-a under LPS stimulation and propofol treated
To be investigated whether Annexin A1 is the key anti-
inflammatory protein of propofol and whether the anti-inflamma-
tory effect of propofol is realized through inhibiting phosphory-
lation of p38, RNAi technology was applied to detect the impact of
propofol on phosphorylation of p38 and the release of IL-1b, IL-6
and TNF-a under LPS stimulation after inhibition of Annexin A1
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shRNA of Annexin A1 by electroporation. Then the lysis of THP-
1 cells were separated on 12% SDS-PAGE gels and transferred to
PVDF membranes for Western blotting analysis of phosphoryla-
tion of p38. Fig. 7C showed that propofol had no impact on
phosphorylation of p38 under LPS stimulation following inhibition
of Annexin A1 (P.0.05). IL-1b, IL-6, and TNF-a mRNA of LPS-
stimulated THP-1 cells were measured by RT-PCR in all the four
Figure 1. Representative 2D gels. Control group(upper), LPS+Intralipid group(middle) and LPS+propofol group(lower). Fifteen of these protein
spots were successfully identified by MALDI-TOF MSMS and by subsequent comparative sequence search in the Mascot database.
doi:10.1371/journal.pone.0027890.g001
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6, and TNF-a had no significantly increased treated by
LPS+propofol compared to LPS group following inhibition of
Annexin A1. (Fig. 7E).
Discussion
The anti-inflammatory effect of intravenous general anesthetic
propofol has gradually attracted people’s attention [10–14]. Many
literatures have reported that propofol can inhibit the release of
inflammatory mediators including IL-1b, IL-6 and TNF-a
[16,17], but the specific mechanism of action for propofol to
inhibit these inflammatory factors and the signal transduction
mechanism are poorly understood, which limits and hinders the
specific clinical application of anti-inflammation for propofol.
Mononuclear cells are the most important effector cells in systemic
inflammatory response [7]. Therefore, a rat model of endotoxemia
was established to conduct two-dimensional electrophoresis
proteomic analysis of blood mononuclear cells in rats and find
inflammation-related proteins regulated by propofol. It was found
after mass spectrometry that some inflammation-related proteins
such as: S100-A8, Annexin A1 and mitochondrial precursoe and
so on were significantly increased in the LPS+propofol treatment
group.
Annexin A1 is a member of the membrane calcium protein
family with the size of 37 KD [26]. Glucocorticoids can regulate its
synthesis and function [27]. Annexin A1 is highly expressed in the
cytoplasm of human and rat neutrophils, mononuclear cells and
macrophages. Annexin A1 can be rapidly mobilized to the surface
of cells for secretion as cells are activated [28]. Some research has
shown that Annexin A1 can inhibit inflammatory response [29–
32]: arthritis has been found in Annexin A1-knockout mice,
accompanied by increased expression of IL-1 and IL-6, and
leukocyte and IL-1b migration was significantly inhibited also in
Annexin A1-knockout mouse models of inflammation, suggesting
that Annexin A1 is closely related to inflammatory response.
Thus, Annexin A1 was selected for further validation and
further study. Western blot analysis showed from the animal level
that in animals with endotoxemia, propofol can increase the
expression of Annexin A1 in blood mononuclear cells, which is in
line with the result of two-dimensional electrophoresis. Mean-
while, detection of the release of inflammatory factors also showed
that propofol can significantly reduce the release of pro-
inflammatory factors (TNF-a, IL-1b, IL-6). Therefore, it can be
speculated that the anti-inflammatory effect of propofol might be
realized through activation of Annexin A1 to reduce the release of
inflammatory factors. This is the first time of detecting the
correlation between the anti-inflammatory effect of propofol and
Annexin A1 at home and abroad.
The mitogen-activated protein kinase (MAPK) is an important
intracellular signal transduction system of mediating extracellular
signal response in cells by eukaryotic cells [33]. The p38 signal
pathway in the MAPK system mainly functions in inflammation.
Pro-inflammatory factors, bacterial components and UV irradia-
tion etc can all activate the p38 pathway [34]. The latest research
reports that Annexin A1 is an endogenous factor negatively
regulating the activity of MAPK and IL-6 [35]. In Annexin A1
2/2
cells, the phosphorylation level of p38 was increased after IL-1
induction of inflammatory response and after given the p38
inhibitor, the release of IL-6 was reduced. Thus, it should be
explored whether the anti-inflammatory effect of propofol can
affect phosphorylation of p38. After detecting the phosphorylation
level of p38 in blood mononuclear cells in rats with endotoxemia,
it has been found that LPS can evidently induce phosphorylation
of p38 and propofol treatment can significantly inhibit phosphor-
ylation of p38, prompting that the anti-inflammatory effect of
propofol is related with the inhibition of phosphorylation of p38.
Nonetheless, it still awaits further investigation whether the
inhibitory effect of propofol on phosphorylation of p38 is directly
realized through up-regulation of Annexin A1 and whether
Annexin A1 is the key protein in the anti-inflammatory
mechanisms of propofol.
In the absence of rat monocytic cell lines, human monocytic cell
line-THP-1 was selected for in vitro study of the anti-inflammatory
mechanism of propofol. First, the impact of propofol on Annexin
A1 and phosphorylation of p38 following LPS stimulation was
Table 1. List of Identified Protein Spots Differentially Expressed in control, LPS, and LPS plus propofol groups.
spot
theoretical
Mr (kDa)
total
score
queries
mached
SwissProt
ID Protein description
1 22.44 152 100 Q4KM73 UMP-CMP kinase
2 18.75 121 100 P45592 Cofilin-1
3 19.81 30 94.68 QAT7M0E3 Destrin
4 10.29 126 100 PA5T0115 Protein S100-A8
5 59.83 306 100 PT15999 ATP synthase subunit alpha, mitochondrial precursor
6 227.57 194 100 QAT62812 Myosin-9
8 15.23 69 99.99 PG1A9014 Hemoglobin subunit alpha
10 36.71 205 100 PT04642 L-lactate dehydrogenase A chain
11 22.85 64 99.95 P24368 Peptidyl-prolyl cis-trans isomerase B precursor
13 22.14 248 100 P29117 Peptidyl-prolyl cis-trans isomerase, mitochondrial precursoe
14 16.08 354 100 PT02091 Hemoglobin subunit beta-1
15 39.15 691 100 P07150 Annexin A1
16 22.46 230 99.99 PT04041 Glutathione peroxidase 1
17 18.83 228 100 QAT6PEC4 S-phage kinase-associated protein 1
18 8.56 320 100 PT62989 Ubiquitin
doi:10.1371/journal.pone.0027890.t001
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that propofol can activate the expression of Annexin A1 no matter
there was LPS stimulation or not and the effect was the most
obvious at 6 h. Correspondingly, propofol can inhibit LPS-
induced increase in the phosphorylation level of p38 and the
inhibitory effect on phosphorylation of p38 was significant at 2 h
and 6 h following propofol treatment. In the meantime, propofol
can reduce the release of inflammatory factors in the supernatant
of THP-1 cells under LPS stimulation, which is in line with the
result from the animal level and once again confirms that the anti-
inflammatory effect of propofol is related to the activation of
Annexin A1 and inhibition of p38 phosphorylation.Lecona E et al.
[36] showed that Annexin A1 promoter activity and protein
expression is increased by activation of p38 MAPK. Thus,
Annexin A1 could be regulated by propofol/p38 activation, and
Annexin A1 should not be the primary protein during propofol’s
Figure 2. Identification of Annexin A1 up-regulation in LPS+propofol group. A. Gels in control(1), LPS(2), and LPS+propofol(3) group has
been enlarged to show the high expression of Annex A1 in three groups. B. The densitometric analysis of each protein was calculated from 9 different
gels using PDQuest software. Each bar represents the mean 6 SD of intensity, the expression of Annex A1 in LPS+prpofol group increased
dramatically compared with LPS+Intralipid group(*p,0.001) and control Group(**p,0.001). C. MSMS of in-gel trypsin digests of the protein and
analysis of the depicted peptide spectrum resulted in the identification of Annex A1.
doi:10.1371/journal.pone.0027890.g002
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PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e27890Figure 3. Confirming the expression of Annexin A1 and phos-p38 in monocytes with Western Blot assay. A. Monocytes lysis samples
from the individual rats were separated on 12% SDS-PAGE gels and transferred to PVDF membranes for Western blotting analysis. B. Gray intensity
analysis of the western blot results of six groups. Each bar represents the mean 6 S.D, (*p,0.01, n=6, compared with the other four groups) C group:
control group; L group: LPS group; P group: propofol group; L+P group: LPS+propofol group; I group: intralipid group; L+I group: LPS+intralipid
group. C. Monocytes lysis samples from the individual rats were separated on 12% SDS-PAGE gels and transferred to PVDF membranes for Western
blotting analysis. D. Gray intensity analysis of the western blot results of four groups. Each bar represents the mean 6 S.D, (**p,0.01, n=6, compared
with the C, P and I groups; ***p,0.05, n=6, compared with the L and L+I groups) C group: control group; L group: LPS group; P group: propofol
group; L+P group: LPS+propofol group; I group: intralipid group; L+I group: LPS+intralipid group.
doi:10.1371/journal.pone.0027890.g003
Figure 4. IL-1b, IL-6 and TNF-a quantitization in the serum of six groups. A. ELISA confirmation of TNF-a in the serum of six groups. Each bar
represents the mean 6 S.D, significant differences were found between L group and L+P Group(*p,0.01, n=6). B. ELISA confirmation of IL-1b in the
serum of four groups. Each bar represents the mean 6 S.D, significant differences were found between L group and L+P Group(*p,0.01, n=6). C.
ELISA confirmation of IL-6 in the serum of four groups. Each bar represents the mean 6 S.D, significant differences were found between L group and
L+P Group (*p,0.01, n=6).
doi:10.1371/journal.pone.0027890.g004
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PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e27890Figure 5. The impact of propofol on Annexin A1 and phosphorylation of p38 following LPS stimulation was validated and the time
and concentration effects were analyzed with Western Blot. A. Lysis samples of THP-1 cells from 5 mg/ml to 50 mg/ml of propofol treated
were separated on 12% SDS-PAGE gels and transferred to PVDF membranes for Western blotting analysis of Annexin A1. B. Gray intensity analysis of
the western blot results of seven groups. Each bar represents the mean 6 S.D, (*p,0.01, n=3, compared with C and L groups in 6 h) C group: control
group; L group: LPS group; L+P(5, 10, 20, 30, 50) group: LPS+different concentration (5, 10, 20, 30, 50 mg/ml)propofol group. C. Lysis samples of THP-1
cells from 1 h to 6 h were separated on 12% SDS-PAGE gels and transferred to PVDF membranes for Western blotting analysis of Annexin A1. D. Gray
intensity analysis of the western blot results of four groups. Each bar represents the mean 6 S.D, (*p,0.01, n=3, compared with C and L groups in
6 h) C group: control group; L group: LPS group; P group: propofol group; L+P group: LPS+propofol group. E. Lysis samples of THP-1 cells from 1 h to
6 h were separated on 12% SDS-PAGE gels and transferred to PVDF membranes for Western blotting analysis of phos-p38. F. Gray intensity analysis of
the western blot results of four groups. Each bar represents the mean 6 S.D, (**p,0.001, compared with the C and P groups in 0.5 h, 1 h, 2 h, 6 h;
**p,0.05, compared with the L groups in 2 h and 6 h, n=3) C group: control group; L group: LPS group; P group: propofol group; L+P group:
LPS+propofol group. G. Lysis samples of THP-1 cells were separated on 12% SDS-PAGE gels and transferred to PVDF membranes for Western blotting
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However, we find that studied models of this two article are not
the same. Lecona E et al. mainly research effects of Annexin A1
and p38 in cell differentiation regulation in human colon
adenocarcinoma cells, while this paper highlights effects of
Annexin A1 and p38 in inflammatory mechanism of propofol,
which is possibly the reason causing two different results.
The solvent of propofol is intralipid, which is reported to have
the anti-inflammatory effect in many literatures and can reduce
the release of inflammatory factors [34]. Thus, after comparison of
intralipid between the in vivo study and the in vitro study of this
experiment, it has been found that lipid emulsion can neither
inhibit the release of inflammatory factors, nor activate the
expression of Annexin A1.
However, it still needs to be investigated whether Annexin A1 is
the key anti-inflammatory protein of propofol and whether the
anti-inflammatory effect of propofol is realized through inhibiting
phosphorylation of p38. To this end, RNAi technology was
applied to detect the impact of propofol on phosphorylation of p38
and pro-inflammatory factors (TNF-a, IL-1b, IL-6) under LPS
stimulation after inhibition of Annexin A1 in THP-1. The results
showed that propofol had no impact on phosphorylation of p38
and pro-inflammatory factors (TNF-a, IL-1b, IL-6) under LPS
stimulation following inhibition of Annexin A1, which is consistent
with the result that Annexin A1 can negatively regulate IL-6
through inhibiting p38MAPK, as recently reported by Yang YH
[37]. The above results fully confirm that the anti-inflammatory
effect of propofol is realized through inhibiting phosphorylation of
p38 after up-regulation of the expression of Annexin A1 in
mononuclear cells. It can be said that Annexin A1 is a key
signaling molecule in the anti-inflammatory mechanism of
propofol.
It is reported that Annexin A1 is mainly regulated by
glucocorticoids, which plays an important role in the signal
transduction pathway of glucocorticoid-mediated anti-inflamma-
tory response and inhibits neutrophil mobilization in several
experimental animal models [27]. That is to say, glucocorticoids
can also activate Annexin A1. In animal experiments, it has been
found that the expression of Annexin A1 was up-regulated in the
propofol group, which might be due to propofol or glucocorticoids
in rats’ bodies. Activation of Annexin A1 by propofol is also
detected in THP-1 in extracellular cells, indicating that Annexin
A1 is activated by propofol, which is irrelevant with glucocorti-
coids.
Our study design did not indicate how propofol regulates the
Annexin A1, although we demonstrated the effect of propofol on
regulating Annexin A1 during LPS inflammation in vivo and vitro,
which is our next research content. In addition, propofol also has
anti-oxidative effect, what is this effect on Annexin A1 expression
is unknown. For our experimental model in the paper, we mainly
investigate effects of propofol on Annexin A1 expression during
pathophysiological process, on p38 phosphorylation through
Annexin A1 and on the release of inflammatory factors in
endotoxemia caused by LPS. While it a very interesting and
meaningful idea that antioxidant effect of propofol in this process
acts to what extent. As inflammation and oxidative stress are
essentially inseparable, oxidative stress can cause inflammation,
and large amounts of oxygen free radicals produced in
inflammatory process will also affect the inflammatory process.
The relationship of the two is so close that it is difficult to
completely separate the two, futher study in needed.
To conclude, the results of our study clearly show that propofol
can up-regulate the expression of Annexin A1 in rats with
endotoxemia and LPS-stimulated THP-1 and the increased
expression of Annexin A1 can also reduce the release of
inflammatory factors. Annexin A1 can also negatively regulate
phosphorylation of p38. Therefore, it can be concluded that the
anti-inflammatory molecular mechanism of propofol might be
realized through inhibiting phosphorylation of p38 and the release
of inflammatory factors following up-regulation of Annexin A1.
Methods
Model building
Experiments were approved by the local council of ethics and
performed in accordance with the Guidelines for the Care and Use
of Nanfang Hospital. To in accordance with the guidelines of the
International Association for the Study of Pain as published in
Pain 1983; 16:109–110, all the operation were done, after animals
were anesthetized with urethane, so animals did not feel pain or
discomfort during the experiments and the minimum possible pain
or stress had been imposed on the animals. Animals adopted from
the experimental animal center of Southern Medical University.
Eighteen Male Sprague-Dawley rats weighing between 180 and
210 g anesthetized with urethane (1.0 g/kg) i.p. were divided into
control, LPS (from Escherichia coli, sigma, USA), propofol(com-
mercial name Diprivan, Astrazeneca, UK), LPS+propofol groups,
intralipid group(sino-swed pharmaceuticalcorp.ltd, China) and
LPS+intralipid group. In the LPS group, rats were infused with
analysis of Annexin A1. H. Gray intensity analysis of the western blot results of six groups. Each bar represents the mean 6 S.D. No significant
differences were found between L group and L+I Group (p.0.05). C group: control group; L group: LPS group; I group: intralipid group; L+I group:
LPS+intralipid group. I. Lysis samples of THP-1 cells were separated on 12% SDS-PAGE gels and transferred to PVDF membranes for Western blotting
analysis of phos-p38. J. Gray intensity analysis of the western blot results of four groups. Each bar represents the mean 6 S.D. No significant
differences were found between L group and L+I Group (p.0.05). C group: control group; L group: LPS group; I group: intralipid group; L+I group:
LPS+intralipid group.
doi:10.1371/journal.pone.0027890.g005
Figure 6. IL-1b, IL-6 and TNF-a quantitization in the serum of
THP-1 cells. ELISA confirmation of TNF-a IL-1b, IL-6 in the serum of
THP-1 cells. Each bar represents the mean 6 S.D, significant differences
were found between L group and L+P Group(*p,0.001, compared with
C and P groups; **p,0.01, compared with the L groups).
doi:10.1371/journal.pone.0027890.g006
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LPS+propofol group rats were injected with LPS followed by
propofol at 10 mg.kg-1h-1. In the intralipid group, rats received a
continuous infusion of 10% IntralipidH(10 mg.kg-1h-1) via the
femoral vein to control for EDTA present in the lipid diluent of
propofol, and in the LPS+intralipid group rates were injected with
LPS followed by intralipid at 10 mg.kg-1h-1. In the control group,
rats were injected the same amount balanced saline. After 6 h, 3–
4 ml of blood from the carotid artery of each rat was collected into
Eppendorf tubes and the rats were sacrificed thereafter.
Isolation of leukocytes from rat peripheral blood
3.0 ml HISTOPAQUE 1083(Sigma) were Added in a 15 ml
centrifuge tubes, then 3.0 ml whole blood were carefully layered
onto the HISTOPAQUE 1083 surface, Centrifuging at 4006g for
exactly 30 minutes at room temperature. After centrifugation, the
upper layer to within 2–3 mm of the opaque interface contained
the mononuclear cells. Carefully aspirated the upper layer with a
Pasteur and discarded it. Carefully transferd the opaque interface,
containing the mononuclear cell band, with a Pasteur pipet, into a
clean 15 ml conical centrifuge tube. Then 10 ml isotonic PBS
were added to to the monuclear cells Mixing the tube by gentle
inversion several times and Centrifuge at 2506g for 10 minutes.
Aspirated the supernatant and discarded it. After resuspending the
cell pellet with 0.5 ml of isotonic PBS, additional 4.5 ml of isotonic
PBS were added to Centrifuge at 2506g for 10 minutes. Aspirated
the supernatant and discarded it. Repeated this step 2–3 times to
remove any remaining HISTOPAQUE 1083 from the mononu-
clear cells. After the final wash, the cells were 300 mL of lysis buffer
consisting of 7 Murea, 2Mthiourea, 4% CHAPS, 65mMDTT and
2% Pharmalyte(pH3-10, GE HealthCare, Piscataway, NJ) by
sonication on ice. The lysates were cleared by centrifugation at
12 000 rcf for 30 min at 4uC twice. Subsequently, the protein
concentration of the supernatants was determined by the modified
Figure 7. The impact of propofol on phosphorylation of p38 and the release of IL-1b, IL-6 and TNF-a under LPS stimulation after
inhibition of Annexin A1 in THP-1. A. Lysis samples of THP-1 cells were separated on 12% SDS-PAGE gels and transferred to PVDF membranes for
Western blotting analysis of Annexin A1. B. Gray intensity analysis of the western blot results of six groups. Each bar represents the mean 6 S.D. No
significant differences were found between L’ group and L’+P’ Group (p.0.05). L group: LPS group with wide-type Annexin A1; L+P group:
LPS+propofol group with wide-type Annexin A1 ; L’ group: LPS group with transfected shRNA of Annexin A1; L’+P’ group: LPS+propofol group with
transfected shRNA of Annexin A1. C. Lysis samples of THP-1 cells were separated on 12% SDS-PAGE gels and transferred to PVDF membranes for
Western blotting analysis of phosphorylation of p38. D. Gray intensity analysis of the western blot results of four groups. Each bar represents the
mean 6 S.D. No significant differences were found between L’ group and L’+P’ Group (p.0.05). L group: LPS group with wide-type Annexin A1; L+P
group: LPS+propofol group with wide-type Annexin A1 ; L’ group: LPS group with transfected shRNA of Annexin A1; L’+P’ group: LPS+propofol group
with transfected shRNA of Annexin A1. E. the experession of mRNA of TNF-a IL-1b, IL-6 in THP-1 cells. Each bar represents the mean 6 S.D, no
significant differences were found L’+P’ group compared with L’ group.
doi:10.1371/journal.pone.0027890.g007
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at 280uC.
2-D electrophoresis
Immobiline Dry strip (pH 4–7, length 24 cm, GE Healthcare)
was rehydrated with 1500 mg protein in 450 ml rehydration buffer
containing 7 M urea, 2 M thiourea, 4% CHAPS, 65 mM DTT,
20 mM Trizma base, 1% IPG buffer and 0.002% bromophenol
blue for 14 h at room temperature. Isoelectric focusing (IEF) was
performed using the Ettan IPGphor 3 IEF System (GE
Healthcare, USA) for a total of 70 kVh. The strip was then
subjected to two-step equilibration in a buffer containing 6 M
urea, 20% glycerol, 2% SDS and 50 mM Tris–HCl (pH 8.8) with
2% w/v DTT for the first step, and 2.5% w/v iodoacetamide for
the second step. The second-dimension SDS-PAGE (12% T,
260620061.5 mm3) was carried out using a Ettan DALTsix
Large Vertical system (Amersham, USA) according to the
following procedures: 45 min at a constant power of 5 watt
followed by 20 watt per gel until the bromophenol blue front
reached the bottom of the gel. Subsequently the gels were stained
with 0.12% w/v Coomassie Brilliant Blue G250. Each group was
run in triplicate to minimize run-to-run variation. The coomassie
blue-stained protein 2D gels were scanned using an Amersham
Biosciences Imagescanner and analyzed using DeCyder software
package (GE Healthcare, USA).
In-gel digestion
Protein spots were excised from gel with an operating knife
blade, destained twice with 30 mM potassium ferricyanide and
100 mM sodium thiosulfate (1:1 v/v) and then equilibrated in
100 mM NH4HCO3 to pH 8.0. After dehydrating with ACN and
drying in N2 at 37uC for 20 min, the gel pieces were rehydrated in
10 ml trypsin solution (12.5 ng/mli n5 0m MN H 4HCO3)a t4 uC
for 30 min and incubated at 37uC overnight. Peptides were
extracted twice using 0.1% TFA in 60% CAN and dried with the
RCT60 (Jouan, France).
MALDI-TOF-MS identification
The peptide mixtures were solubilized with 0.1% TFA and
desalted with C18 ZipTip (Millipore, USA). The peptide was then
eluted by saturated a-cyano-4-hydroxy-trans-cinnamic (CHCA)
solution in 0.1% TFA/60% acetonitrile as the matrix and
analyzed using 4800 MALDI TOF/TOF Analyzer (Applied
Biosystems, USA). Mass spectra were internally calibrated with
angiotensin I (Mr: 1296.6853).
Protein identification and database searching
Protein identificationusingpeptidemassfingerprinting(PMF) and
peptide sequence tag (PST) was performed by the MASCOT search
engine (http://www.matrixscience.com/, MatrixSicence Ltd., Lon-
don, UK) against the SwissProt protein database. The errors in
peptide masses were in the range of 50 ppm. One missed tryptic
cleavage site per peptide was allowed during the search. Proteins
matching more than four peptides and with a MASCOT score
higher than 64 were considered significant (P,0.05). Carboamido-
methylation of cysteine was selected as the fixed modification and
oxidation of methionine as the variable modification. Protein
identification results were filtered with GPS software.
Cell culture and reagents
The human monocytic THP-1 cells from the American Type
Culture Collection(ATCC) were cultured in RPMI1640(Gibco
BRL, Grand Island, NY, USA) supplemented with 10% fetal calf
serum (FCS)(Gibco BRL, Grand Island, NY, USA) in 75-cm
2
flasks at 37uC in a humidified atmosphere of 5% CO2. The
cultured THP-1 cells were randomly assigned to one of the
following six groups: Group 1: cells in untreated group(control)
was cultured for 6 h in the absence of propofol and LPS; Group 2:
treated with 10 mg/ml LPS for 6 h; Group 3: treated with 20 mg/
ml propofol for 6 h; Group 4: treated with 10 mg/ml LPS and
20 mg/ml propofol for 6 h; Group 5: treated with 20 mg/ml
intralipid(the solvent for propofol) for 6 h; Group 6: treated with
10 mg/ml LPS and 20 mg/ml intralipid for 6 h;
Transient transfection of Annexin A1 shRNA into THP-1
cells
shRNA of Anneinx A1 were synthesis by Gene Pharma RNAi
Cmpany. The sequence were: 59 CCCUGGAUGAAACACU-
UAATT 39;5 9GCAGGAAUAUGUUCAAACUTT 39;5 9GCC-
UUGCAUAAGGCCAUAATT 39. The shRNA and negative
control shRNA were transfected into THP-1 cells by electropo-
ration. THP-1 cells (1610
3) were washed in PBS and then
centrifuged and resupended in 100 ul R buffer; 100 nM shRNA
was then added. Electroporation was performed using a
NEON(1500 V, 20 ms, 2 N). After discharging, cells were
transferred into 500 ul containing 10% fetal serum medium and
further incubated 24 h under atmospheric conditions of 95% air-
5% CO2 at 37uC.
Western Blot Analysis
Annexin A1 and phospho-p38MAPK(Thr180/Tyr182) in the
mononuclear cells of rats and THP-1 cells were detected by western
blot analysis. The mononuclear cells of rats and THP-1 cells were
lysed on ice in 300 ml cell lysis buffer [16PBS, 1% NP40, 0.1%
sodium dodecyl sulfate (SDS), 5 mM EDTA, 0.5% sodium
deoxycholate, and 1 mM sodium orthovanadate] with protease
inhibitors. Protein concentration was determined by the modified
Bradford method. Equal amounts of proteins were separated
electrophoretically on 12% SDS/polyacrylamide gels and trans-
ferred onto polyvinylidene difluoride membranes (PVDF) (Amer-
sham Pharmacia Biotech, Piscataway, NJ). For Annexin A1
detecting, the membrane was probed with anti-Annexin A1 rabbit
polyclonal antibody (1:2000; Cell Signaling Technology) and
horseradish peroxidase-conjugated anti-rabbit immunoglobulin G
(1:2000; Cell Signaling Technology, Danvers MA); For Phospho-
p38MAPK detecting, the membrane was probed with anti-
Phospho-p38MAPK (Thr180/Tyr182) rabbit polyclonal antibody
(1:1000; Cell Signaling Technology, Danvers MA) and horseradish
peroxidase-conjugated anti-rabbit immunoglobulin G (1:2000; Cell
Signaling Technology, Danvers MA); For total p38MAPK
detecting, the membrane was probed with anti-p38MAPK rabbit
polyclonal antibody (1:1000; Cell Signaling Technology, Danvers
MA) and horseradish peroxidase-conjugated anti-rabbit immuno-
globulin G (1:2000; Cell Signaling Technology, Danvers MA); For
b-actin detecting, the membrane was probed with anti-b-actin
(HRP-Conjugate) rabbit monoclonal antibody (1:1000; Cell
Signaling Technology, Danvers MA).
ELISA
To test the amount of IL-1b, TNF-a and IL-6 in the sera of
another 24 SD rats and the supernatant of THP-1 cells were
randomized into same treatment groups. Measurements were
carried out using commercially available ELISA kits (Rat or
Human IL-1b ELISA Kit eBioscience, Rat or Human TNF-a
ELISA Kit Uscnlife, Rat or Human IL-6 ELISA Kit Thermo
Scientific), in accordance with the manufacturer’s instructions. All
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measured. Both standards and samples were run in duplicate.
Reverse transcriptase-polymerase chain reaction
Total RNA was extracted from treated THP-1 cells using
TRIzol reagent (Gibco BRL, Grand Island, NY) and subsequently
underwent reverse transcription, according to the manufacturer’s
protocol. IL-1b, TNF-a, IL-6 and b-actin were amplified using
polymerase chain reaction (PCR) with gene-sepcific primers
(Table 2). PCR products were visualized on 2% agarose gels
containing ethidium bromide. b-actin was the internal control.
The relative quantity of PCR products is expressed as fold increase
relative to PBS controls.
Statistical Analysis
All the data was tested for normal distribution before statistical
analysis and the statistic analysis were carried out using the
SPSS13.0. All data was and expressed as mean 6 S.D. Multiple
groups were compared using analysis of variance (ANOVA)
followed by Student-Newman-Keuls post hoc procedure. Changes
were identified as significant when P,0.05.
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